Supply Chain Is Your Fastest Path to Margin Improvement in 2026

A practical look at the supply chain pressures ahead—and the actions healthcare leaders can take now to protect margin and performance.

Healthcare leaders don’t need another reminder that margins are tight. What’s changing in 2026 is where the most immediate opportunity—and risk—now sits.

Supply chain.

In our recent webinar, From Volatility to Value: Strategic Supply Chain Priorities in 2026, we explored why supply chain has become one of the most critical levers for financial and operational performance—and what organizations can do right now to respond.

“When you look at supply chain in totality, it can represent up to 50% of your cost structure.”

That reality alone is reshaping how leading organizations think about cost management.

The Environment Has Changed—Permanently

The supply chain challenges facing healthcare organizations today are not temporary disruptions. They represent a new operating environment.

Across the industry, leaders are navigating:

  • Tariff-driven cost volatility
  • Persistent inflation in purchased services and IT
  • Ongoing supply disruptions as a “normal state”
  • Vendor consolidation reducing negotiating leverage
  • Care shifting into non-acute settings
  • Increasing cybersecurity exposure across supplier networks

These forces are interconnected—and they’re accelerating.

“Supply disruptions are not going away. Providers need to plan for them—not react to them.”

The implication is clear: reactive supply chain management is no longer sufficient.

Where We See the Biggest Opportunity

While many organizations are still focused on traditional sourcing and contracting, the most significant opportunities today lie in areas often overlooked.

1. Purchased Services

One of the most under-managed—and highest impact—areas we see is purchased services.

These categories often operate like “micro-businesses” across the organization, with:

  • Limited central oversight
  • Inconsistent contract adherence
  • Missed opportunities for scale and standardization
“Purchased services is one of the largest untapped opportunities we see across health systems today.”

Bringing structure, visibility, and governance to this area can unlock meaningful savings.

2. Clinical Variation and Utilization

Clinical variation remains a major driver of cost, and one that many organizations have not fully readdressed post-pandemic.

Re-engaging clinicians through structured value analysis programs is critical to:

  • Standardizing products and protocols
  • Improving outcomes while managing cost
  • Aligning supply decisions with clinical priorities

3. Contract Leakage and Compliance

Even well-negotiated contracts fail to deliver value if they are not consistently followed.

We continue to see:

  • Off-contract purchasing
  • Non-catalog ordering
  • Limited enforcement of compliance controls

Addressing these gaps is often one of the fastest ways to recover margin.

What Leaders Should Do Now

The organizations that will perform best in 2026 are not those trying to control everything; they are the ones focused on what can be controlled.

Build a More Resilient Operating Model

Resiliency is not about carrying more inventory. It’s about:

  • Having predefined substitution plans
  • Establishing supply disruption response teams
  • Building flexibility into contracts

Move Beyond Unit Price Thinking

Focusing only on price is no longer enough.

Leading organizations are shifting toward total delivered cost, factoring in:

  • Freight and logistics
  • Inventory carrying costs
  • Contract escalators and tariff clauses

Strengthen Governance and Visibility

Data transparency is critical.

A “control tower” approach—combining analytics, dashboards, and executive visibility—enables faster, more informed decisions and prevents cost creep over time.

Rethink Value Analysis for Speed and Impact

Traditional value analysis processes are often too slow for today’s environment.

A tiered approach—ranging from quick “just do it” decisions to service line-level reviews—can accelerate decision-making while maintaining clinical alignment.

The Bottom Line

Supply chain is no longer a back-office function. It is a strategic driver of performance.

Organizations that treat it that way—by improving governance, aligning clinical and operational decision-making, and focusing on total cost—will be better positioned to navigate the volatility ahead.

Those that don’t will continue to feel the pressure.

What to Do Next

If you’re evaluating where to focus next, supply chain is one of the fastest paths to measurable impact.

Our team works alongside healthcare leaders to:

  • Identify hidden cost opportunities
  • Strengthen supply chain governance
  • Align clinical, operational, and financial priorities
  • Build more resilient, future-ready supply chain models

Connect with our team to explore how we can support your organization’s supply chain strategy.

Social Share

Related Insights